Works matching IS 11707690 AND DT 2004 AND VI 22 AND IP 15

Results: 5

Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.
Published in:
2004
By:
- Schädlich, Peter K.;
- Brecht, Josef Georg;
- Rangoonwala, Badrudin;
- Huppertz, Eduard;
- Schädlich, Peter K
Publication type:
journal article
Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?
Published in:
2004
By:
- Babazono, Akira;
- Miyazaki, Motonobu;
- Une, Hiroshi;
- Yamamoto, Eiji;
- Tsuda, Toshihide;
- Mino, Yoshio;
- Hillman, Alan L.
Publication type:
journal article
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Published in:
2004
By:
- Pradalier, André;
- Auray, Jean-Paul;
- El Hasnaoui, Abdelkader;
- Alzahouri, Kazem;
- Dartigues, Jean-François;
- Duru, Gérard;
- Henry, Patrick;
- Lantéri-Minet, Michel;
- Lucas, Christian;
- Chazot, Guy;
- Gaudin, Anne-François;
- Pradalier, André;
- Dartigues, Jean-François;
- Duru, Gérard;
- Lantéri-Minet, Michel;
- Gaudin, Anne-François
Publication type:
journal article
Comparisons of hypertension-related costs from multinational clinical studies.
Published in:
2004
By:
- Mullins, C. Daniel;
- Sikirica, Mirko;
- Seneviratne, Viran;
- Ahn, Jeonghoon;
- Akhras, Kasern S.;
- Akhras, Kasem S
Publication type:
journal article
Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
Published in:
2004
By:
- Dong, Frederick B.;
- Sorensen, Stephen W.;
- Mannien, Diane L.;
- Thompson, Theodore J.;
- Narayan, Venkat;
- Orians, Carlyn E.;
- Gregg, Edward W.;
- Eastman, Richard C.;
- Dasbach, Erik J.;
- Herman, William H.;
- Newman, Jeffrey M.;
- Narva, Andrew S.;
- Ballard, David J.;
- Engelgau, Michael M.;
- Manninen, Diane L
Publication type:
journal article

Works matching IS 11707690 AND DT 2004 AND VI 22 AND IP 15

Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspective.

Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Comparisons of hypertension-related costs from multinational clinical studies.

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.